Fulcrum Therapeutics Inc
(NAS:FULC)
$
3.32
0.06 (1.84%)
Market Cap: 207.17 Mil
Enterprise Value: -60.70 Mil
PE Ratio: 0
PB Ratio: 0.75
GF Score: 51/100 Fulcrum Therapeutics Inc at Bank of America Biotech SMID Cap Conference Transcript
Dec 08, 2022 / 02:10PM GMT
Release Date Price:
$6.14
Operator
Ladies and gentlemen, the program is about to begin. Reminder that you can submit questions at any time via the ask questions tab on the webcast page. At this time, it is my pleasure to turn the program over to your host, Tazeen Ahmad.
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
Great. Thanks, Joe. Good morning, everybody, and thanks for joining us again at the BofA Virtual SMID Biotech Conference. It's my pleasure to have our next presenting company, Fulcrum Therapeutics and presenting for Fulcrum for the next 30 minutes will be CEO, Bryan Stuart. Bryan, good morning. Thank you for joining us.
Bryan E. Stuart
Fulcrum Therapeutics, Inc. - President, CEO & Director
Yes. Good morning, Tazeen. Thanks for having us.
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
All right. So we only have 30 minutes together today. So I think there's a lot going on at the company. So I
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot